IVVD Stock: Invivyd, Inc. Stock Price, Analysis & Insights
Get live ivvd stock price $2.35, comprehensive Invivyd, Inc. stock analysis, charts, news, and expert forecast. Real-time ivvd stock data and investment insights.
Loading chart...
Company Overview
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatment and prevention of coronavirus disease. Adagio Therapeutics, Inc. has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies; and the Scripps Research Institute to perform research activities to identify vaccine candidates for the prevention, diagnosis or treatment of influenza or beta coronaviruses. The company was incorporated in 2020 and is based in Waltham, Massachusetts.
Company Information
- CEO
- William E. Duke Jr.,
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 99
Contact Information
- Website
- https://adagiotx.com
- Address
- 1601 Trapelo Road
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Lower volatility stock (Beta: 0.64) may provide portfolio stability
Business Model & Strategy
Invivyd, Inc. operates in the Biotechnology industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO William E. Duke Jr.,, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Biotechnology model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Invivyd, Inc. competes in the Biotechnology within the broader Healthcare. With 311.9 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Global Market, Invivyd, Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Invivyd, Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Invivyd, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Invivyd, Inc.
- ⚠Investors should consider how Invivyd, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
311.91M
P/E Ratio
-5.22
Beta
0.64
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 311.91M market capitalization
- Trading Volume: 136.45M shares traded today
- Price Range: 52-week range of $0.35 - $2.76
- Exchange: Listed on NASDAQ Global Market
Financial Metrics
Market Analysis for Invivyd, Inc.
Invivyd, Inc. (IVVD) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 311.91M, the company represents a significant player in its market. The stock is currently trading at $2.35 with a positivedaily change of 32.77%.
The company's 99 employee base and presence on the NASDAQ Global Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -5.22, beta of 0.64, and 52-week price range from $0.35 to $2.76when evaluating investment opportunities.
Why Invest in Invivyd, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Global Market)
- • Experienced leadership under William E. Duke Jr.,
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.